Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Appco Pharma LLC | Piscataway, NJ, United States | Makes it, tests it and packages it | Problems found, fixed voluntarilyMay 14, 2026 · 9 inspections |
Recalls
- Mar 27, 2026 · Class II · Appco Pharma LLC
cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impurity C (NNP) above acceptable limits.
Lots: Lot:2404160C, Exp.:2026/MAR; 2406253C, Exp.:2026/MAY; 2407311C, Exp.: 2026/JUL; 2407312C, Exp.:2026/JUL; 2408350C, Exp.:2026/JUL; 2505172C, Exp.:2027/MAY; 2506191C, Exp.: 2027/JUN. - Mar 27, 2026 · Class II · Appco Pharma LLC
cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impurity C (NNP) above acceptable limits.
Lots: Lot:2404153UC, Exp.: 2026/MAR; 2404154UC, Exp.:2026/MAR; 2502055UC, Exp.: 2027/JAN; 2505173UC, Exp.: 2027/MAY; 2505175UC, Exp.: 2027/MAY. - Mar 27, 2026 · Class II · Appco Pharma LLC
cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impurity C (NNP) above acceptable limits.
Lots: Lot:2406255UC, Exp.: 2026/MAY; 2406256UC, Exp.: 2026/JUL; 2407313UC Exp.: 2026/JUL; 2408351UC, Exp.: 2026/JUL; 2408352UC , Exp.: 2026/JUL; 2509311UC, Exp.: 2027/SEP. .
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Prazosin: every company that makes it
- Form
- capsule, oral
- Strength
- 2 mg
- Approval
- ANDA ANDA213406
- On the market since
- Jan 9, 2023
- Package NDCs
70377-067-11- Official label
- DailyMed (National Library of Medicine), updated Oct 23, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?